MO34-3 The efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy for PD-L1-positive EGFR-mutant NSCLC: NJLCG2202.
Saved in:
| Title: | MO34-3 The efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy for PD-L1-positive EGFR-mutant NSCLC: NJLCG2202. |
|---|---|
| Authors: | Kawashima, Y.1 (AUTHOR), Inomata, M.2 (AUTHOR), Saito, R.3 (AUTHOR), Morinaga, D.4 (AUTHOR), Nogawa, H.5 (AUTHOR), Satou, M.6 (AUTHOR), Suzuki, Y.7 (AUTHOR), Yanagisawa, S.8 (AUTHOR), Kikuchi, T.9 (AUTHOR), Jingu, D.10 (AUTHOR), Yoshimura, N.11 (AUTHOR), Harada, T.12 (AUTHOR), Miyauchi, E.3 (AUTHOR) |
| Source: | Annals of Oncology. Oct2024:Supplement 3, Vol. 35, pS1344-S1345. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180495645 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MO34-3 The efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy for PD-L1-positive EGFR-mutant NSCLC: NJLCG2202. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kawashima%2C+Y%2E%22">Kawashima, Y.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inomata%2C+M%2E%22">Inomata, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saito%2C+R%2E%22">Saito, R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morinaga%2C+D%2E%22">Morinaga, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nogawa%2C+H%2E%22">Nogawa, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Satou%2C+M%2E%22">Satou, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Suzuki%2C+Y%2E%22">Suzuki, Y.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yanagisawa%2C+S%2E%22">Yanagisawa, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kikuchi%2C+T%2E%22">Kikuchi, T.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jingu%2C+D%2E%22">Jingu, D.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshimura%2C+N%2E%22">Yoshimura, N.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harada%2C+T%2E%22">Harada, T.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miyauchi%2C+E%2E%22">Miyauchi, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Oct2024:Supplement 3, Vol. 35, pS1344-S1345. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180495645 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.07.573 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1344 Titles: – TitleFull: MO34-3 The efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy for PD-L1-positive EGFR-mutant NSCLC: NJLCG2202. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kawashima, Y. – PersonEntity: Name: NameFull: Inomata, M. – PersonEntity: Name: NameFull: Saito, R. – PersonEntity: Name: NameFull: Morinaga, D. – PersonEntity: Name: NameFull: Nogawa, H. – PersonEntity: Name: NameFull: Satou, M. – PersonEntity: Name: NameFull: Suzuki, Y. – PersonEntity: Name: NameFull: Yanagisawa, S. – PersonEntity: Name: NameFull: Kikuchi, T. – PersonEntity: Name: NameFull: Jingu, D. – PersonEntity: Name: NameFull: Yoshimura, N. – PersonEntity: Name: NameFull: Harada, T. – PersonEntity: Name: NameFull: Miyauchi, E. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: Oct2024:Supplement 3 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |